Key result
Cardiac angiosarcomas exhibited peculiar POTE-gene family overexpression compared to extra-cardiac angiosarcomas, which had more recurrent H/N/K-RAS and TP53 alterations.
Why the study?
Cardiac angiosarcomas are rare, aggressive malignancies, and identifying genomic differences and similarities between cardiac and extra-cardiac angiosarcomas may enhance targeted therapies and patient prognosis.
Observational (n=23)
Cardiac angiosarcomas exhibit a distinct genomic profile characterized by POTE-gene family overexpression, which may contribute to their aggressive phenotype and serve as a potential therapeutic target.
Angiosarcomas (ASs) are rare malignant vascular entities that can affect several regions in our body, including the heart. Cardiac ASs comprise 25–40% of cardiac sarcomas and can cause death within months of diagnosis. Thus, our aim was to identify potential differences and/or similarities between cardiac and extra-cardiac ASs to enhance targeted therapies and, consequently, patients’ prognosis. Whole-transcriptome analysis of three cardiac and eleven extra-cardiac non-cutaneous samples was performed to investigate differential gene expression and mutational events between the two groups. The gene signature of cardiac and extra-cardiac non-cutaneous ASs was also compared to that of cutaneous angiosarcomas (n = 9). H/N/K-RAS and TP53 alterations were more recurrent in extra-cardiac ASs, while POTE-gene family overexpression was peculiar to cardiac ASs. Additionally, in vitro functional analyses showed that POTEH upregulation conferred a growth advantage to recipient cells, partly supporting the cardiac AS aggressive phenotype and patients’ scarce survival rate. These features should be considered when investigating alternative treatments.
No takes yet. Share an insight, caveat, or question.
Gozzellino et al. (2023) conducted an observational in Angiosarcomas (n=23). Cardiac angiosarcomas vs. Extra-cardiac angiosarcomas was evaluated on Differential gene expression and mutational events. Cardiac angiosarcomas exhibited peculiar POTE-gene family overexpression compared to extra-cardiac angiosarcomas, which had more recurrent H/N/K-RAS and TP53 alterations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: